Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Ganga Pharmaceuticals IPO and Wealth First NSE SME IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Wealth First NSE SME IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | First Overseas Capital Limited | Sarthi Capital Advisors Private Limited |
| Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Wealth First NSE SME IPO is up to ₹8.40 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Wealth First NSE SME IPO is ₹50.00 per share.
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹50.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 10,24,000 shares | 16,80,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹8.40 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Wealth First NSE SME IPO opens on Mar 10, 2016. The closing date of Ganga Pharmaceuticals IPO and Wealth First NSE SME IPO is Feb 09, 2016, and Mar 18, 2016, respectively.
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Mar 10, 2016 |
| Issue Close | Feb 09, 2016 | Mar 18, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to Wealth First NSE SME IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 91.05% | |
| Promoter Shareholding (Post-Issue) | 68.09% | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27%% |
In the Ganga Pharmaceuticals IPO retail investors (RII) are offered while in Wealth First NSE SME IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Wealth First NSE SME IPO.
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 56,000 shares | |
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Ganga Pharmaceuticals IPO subscribed in total, whereas Wealth First NSE SME IPO subscribed .
| Ganga Pharmaceuticals IPO | Wealth First NSE SME IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
